In light of the recently announced plan to put 2.5 million people on injectable pre-exposure prophylaxis (PrEP), specifically lenacapavir, by 2027, AI ...
Speaking at the 16th International Aids Conference in 2006, the then UNAids executive director, Peter Piot, remarked: "Since ...
HIV stigma and discrimination continue to harm the lives of people living with HIV, and hinder efforts to stem the epidemic ...
An NPR investigation found Louisiana health officials told staff to stop promoting vaccines for COVID, flu and mpox, holding ...
What does the HIV response look like beyond the 2030 targets to end AIDS? For the past year, UNAIDS has been working with ...
Gilead Sciences will no longer provide four HIV medicines for free as part of a patient assistance program starting at the ...
Assia Ezzahraoui, 25, a participant in Tibu Africa’s Sports Vocational School program, reflects: “HIV awareness was a ...
There is hope for a new 5 by 3 global target of getting 5 million people on long-acting PrEP to prevent HIV by 2030.
As we mark the holidays, here are a few of the many heroes who are working to build a stronger global health future by ...
7d
Data shows the City of Atlanta ranks third in the U.S. for new HIV diagnoses, at more than double the national average.
LONDON (Reuters) - A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or ...
The number of HIV patients in Florida has steadily climbed over the past five years. During HIV/AIDS Awareness Month, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback